Diagnostic efficacy of transrectal ultrasound-guided biopsy of the prostatic fossa in patients with rising PSA following radical prostatectomy

To evaluate the diagnostic efficacy of transrectal ultrasound (TRUS)-guided biopsy of the prostatic fossa in men with biochemical relapse following radical retropubic prostatectomy (RP). Thirty patients, with detectable prostate specific antigen (PSA) and negative imaging for metastases after RP, were evaluated for local recurrence. All patients underwent TRUS-guided biopsies of the prostatic fossa, with at least six cores obtained. PSA and digital rectal examination (DRE) were correlated with biopsy results. Twelve patients (40%) were found with local recurrence. Sensitivities of TRUS and DRE were 75 and 50%, while specificities were 83 and 100%, respectively. Local recurrence was detected in 25% of the patients with PSA ≤ 1 ng/ml, and higher PSA levels were correlated with an increased positive biopsy rate. All patients with positive DRE had positive biopsy and positive TRUS as well. When both TRUS and DRE were positive it was more likely for the patient to have positive biopsy than when both TRUS and DRE were negative. TRUS-guided biopsy is an efficient tool in detecting local recurrence after RP and should be offered to all patients with biochemical relapse and absence of metastatic disease irrespective of the level of PSA.

[1]  P. Carroll,et al.  Radiation therapy for the management of biopsy proved local recurrence after radical prostatectomy. , 1998, The Journal of urology.

[2]  J. Melamed,et al.  The role of bladder neck biopsy in men undergoing radical retropubic prostatectomy with preservation of the bladder neck. , 1998, The Journal of urology.

[3]  F. Montorsi,et al.  Multiple vesico-urethral biopsies following radical prostatectomy: the predictive roles of TRUS, DRE, PSA and the pathological stage. , 2003, European urology.

[4]  D. Kapoor,et al.  Transrectal US in evaluation of patients after radical prostatectomy. Part II. Transrectal US and biopsy findings in the presence of residual and early recurrent prostatic cancer. , 1992, Radiology.

[5]  D. Ornstein,et al.  Evaluation and management of men whose radical prostatectomies failed: results of an international survey. , 1998, Urology.

[6]  Galina Pizov,et al.  Correlation of pathologic findings with progression after radical retropubic prostatectomy , 1993, Cancer.

[7]  M. D. Saleem,et al.  Factors predicting cancer detection in biopsy of the prostatic fossa after radical prostatectomy. , 1998, Urology.

[8]  D. Kapoor,et al.  Transrectal US in evaluation of patients after radical prostatectomy. Part I. Normal postoperative anatomy. , 1992, Radiology.

[9]  P. Lange,et al.  Prostate specific antigen and local recurrence after radical prostatectomy. , 1990, The Journal of urology.

[10]  D. Grignon,et al.  Vesicourethral anastomosis biopsy after radical prostatectomy: predictive value of prostate-specific antigen and pathologic stage. , 1999, Urology.

[11]  J. Fowler,et al.  Original Articles: Prostate Cancer: Variable Histology of Anastomotic Biopsies With Detectable Prostate Specific Antigen After Radical Prostatectomy , 1995 .

[12]  A. Partin,et al.  Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control. , 1997, The Urologic clinics of North America.

[13]  S. Cha,et al.  Irradiation for locally recurrent carcinoma of the prostate following radical prostatectomy. , 1997, Urology.

[14]  P. Carroll,et al.  Is anastomotic biopsy necessary before radiotherapy after radical prostatectomy? , 2001, The Journal of urology.

[15]  A. Partin,et al.  Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. , 1994, Urology.

[16]  A W Partin,et al.  Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. , 1997, JAMA.

[17]  S. Shariat,et al.  Local recurrence after radical prostatectomy: correlation of US features with prostatic fossa biopsy findings. , 2001, Radiology.

[18]  J. Oesterling,et al.  Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. , 1994, The Journal of urology.

[19]  P. Carroll,et al.  Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. , 1996, Urology.

[20]  R. Huben,et al.  The use of transrectal ultrasound in the detection and evaluation of local pelvic recurrences after a radical urological pelvic operation. , 1990, The Journal of urology.

[21]  A W Partin,et al.  Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. , 1993, The Urologic clinics of North America.

[22]  R. Vessella,et al.  The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels. , 1990, The Journal of urology.

[23]  J. Fowler,et al.  Variable histology of anastomotic biopsies with detectable prostate specific antigen after radical prostatectomy. , 1995, The Journal of urology.

[24]  J A Smith,et al.  Results of radical prostatectomy in men with clinically localized prostate cancer. , 1996, JAMA.

[25]  J. Forman,et al.  THERAPEUTIC IRRADIATION FOR PATIENTS WITH AN ELEVATED POST-PROSTATECTOMY PROSTATE SPECIFIC ANTIGEN LEVEL , 1997 .

[26]  M. Carducci,et al.  Management of patients with rising prostate-specific antigen after radical prostatectomy. , 2000, Urology.

[27]  D. Wood,et al.  Incidence of benign and malignant prostate tissue in biopsies of the bladder neck after a radical prostatectomy. , 1995, The Journal of urology.

[28]  S. Schild,et al.  The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy. , 1996, The Journal of urology.